Skip to content

Effectiveness of 5 session treatment consisting motivational enhancement therapy and cognitive behavioral tharapy (MET/CBT5) in treatment of cannabis use disorder in transitional age

studying effectiveness of 5 session treatment consisting motivational enhancement therapy and cognitive behavioral therapy (MET/CBT5) based on cannabis youth treatment (CYT) manual, on cannabis use disorder treatment, in patients diagnosed with cannabis use disorder aged 16-25 years

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230402057796N1
Enrollment
7
Registered
2023-09-09
Start date
2023-05-22
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cannabis Use Disorder. Cannabis abuse, uncomplicated

Interventions

Intervention 1: Intervention group: MET/CBT5 (5 session treatment including cognitive behavioral therapy and motivation enhancement therapy). Intervention 2: Control group: in waiting list for treatme

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
16 Years to 25 Years

Inclusion criteria

Inclusion criteria: Male Gender Age >=16 years and =<25 years Diagnosis of Cannabis Use Disorder Patient's Agreement for participation in 5 therapy sessions

Exclusion criteria

Exclusion criteria: Diagnosis of bipolar mood disorder Diagnosis of psychotic disorders Diagnosis of major depressive disorder

Design outcomes

Primary

MeasureTime frame
Percentage of People completing 5 sessions. Timepoint: The end of 5th session. Method of measurement: counting number of people completed the 5 sessions.;Cure, defined as abstinence(no use) in last 1 month. Timepoint: The end of study. Method of measurement: Patients self report.;Number of days of abstinence at the end of the study. Timepoint: The end of the study. Method of measurement: Patients self report.;The amount of cannabis use , defined as number of use in a week. Timepoint: The ?beginning and end of the study. Method of measurement: Patients self report.

Secondary

MeasureTime frame
Motivation. Timepoint: Before the first session and after finishing fifth treatment session. Method of measurement: 22-item questionnaire validated in iran in 2016.;Other substance use. Timepoint: Before the first session and after finishing fifth treatment session. Method of measurement: Patients self report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHoora Noorbakhsh

Tehran University of Medical Sciences

hoora.noorbakhsh@gmail.com+98 21 5541 9151

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026